The findings are reported in the article «A Sox2 distal enhancer cluster regulates embryonic stem
cell differentiation potential» published online December 15 in Genes & Development.
Not exact matches
Breastmilk is a novel source of stem
cells with multilineage
differentiation potential.
Stem
cells have also been identified in human milk, and have the
potential to differentiate into mammary epithelial lineages under mammary
differentiation conditions in vitro, as well as other
cell types in corresponding microenvironments, including bone
cells, brain
cells, liver
cells, pancreatic beta
cells and heart
cells.
The study focuses on «stemness,» defined as the
potential for self - renewal and
differentiation from the
cell of origin, and on «stemness indices» developed during postdoctoral research conducted by Tathiane Malta as part of a project supported by FAPESP and with Houtan Noushmehr, a professor in FMRP - USP's Genetics Department, as principal investigator.
These findings reveal molecular factors that can be used to evaluate the
differentiation potential of different
cell lines, which should expedite the progress of iPS
cells to clinical use.
Seeking fresh sources, they looked for
cells that express the gene neurogenin 3, a
potential sign of
cell differentiation because it is the first gene to only switch on in pancreatic islets during embryonic development.
Special focus is placed on Rho - kinase inhibition, relating to its
potential to promote and support extracellular matrix production in cultured chondrocytes and its role in fibroblast
cells as a part of direct chemical cellular
differentiation.
«It suggests to us that targeting the pathways used in regulating
cell fate decisions — how stem
cells choose between
cell proliferation and
differentiation — could be a more effective way of halting tumours in their tracks and lead to
potential new therapies.»
Researchers assessing the cardiac
differentiation potential of several adipose - derived stem
cells describe an optimal
cell source
The
differentiation of patient - specific induced pluripotent stem
cells (iPSCs) into has the
potential to provide differentiated
cells to test drugs, model diseases, and, most importantly, to replace lost or damaged tissues.
harnessing the
differentiation potential of pluripotent stem
cells to derive interspecies chimera with
potential clinical applications.
The exploration of the therapeutic
potential of stem
cells requires the characterization of their biological properties, the deciphering of the mechanisms that underlie their pluripotency and their capacity at
differentiation, by the understanding of the signals that direct their fate towards discrete
cell phenotypes... Their therapeutic use requests further, in particular in the case of substitutive therapies, the analysis of their capacities of integration in injured adult tissues and of their
potential tumorigenicity, as well as the development of original ways of delivery.
Finally, I will show how we have combined our results to generate a model of hematopoietic
differentiation where specific transcription factors control lineage regulatory regions; our model predicts many already known lineage - controlling factors as well as finds new
potential regulators of hematopoietic
differentiation such as ATF3 in monocytes and Tcf7l2 and Runx2 in NK
cells.
We have specifically studied the
potential of endothelial
differentiation of MSC and the impact of a tyrosine kinase inhibitor (Imatinib mesylate) on this type of stem
cells.
With
potential therapeutic implications, Stainier and a colleague also recently discovered that endothelial
cells, which line the blood vessels, play a critical role in inducing the development, or proper
differentiation, of red blood
cells, the transporters of oxygen.
Ihor Zahanich (Ravens, TUD)-- «
Differentiation potential of human mesenchymal stem
cells: expression of molecular markers, ion channels and gap junction channels» (2006)
Researchers from the Sloan - Kettering Institute, led by Dr. Lorenz Studer, have discovered a novel type of neural stem
cell, which has a broader
differentiation potential than previously identified neural stem
cells.
Comparison of the
differentiation potential of
cell populations isolated from human lipoaspirate, trabecular bone tissue and periosteal tissue.
Dr. Studer and colleagues isolated and cloned a population of neural rosette
cells (R - NSCs), which have an expanded neuronal subtype
differentiation potential.
[3] H. Lin et al., «Influence of decellularized matrix derived from human mesenchymal stem
cells on their proliferation, migration and multi-lineage
differentiation potential,» Biomaterials, 33:4480 − 9, 2012.
Andreas Ettinger (Huttner, MPG)-- «Release of post-abscission midbodies from stem and cancer
cells and
potential links to
differentiation» (2010)
When a stem
cell divides, it has the
potential to either remain as a stem
cell (process known as «self - renewal») or to become a different type of
cell with a more specialized function («
differentiation»).
An improved
differentiation strategy allows the production of iPSC - derived lung
cells with improved regenerative and reparative
potential.
Stem
cells are the most favorable
cell source for
cell therapy, due to their inherent self - renewal properties and
differentiation potential.
Applying these paradigms on various neural
differentiation schemes of human pluripotent stem
cells allows us to identify and isolate new types of neural stem and progenitor
cells, to characterize their cellular properties and molecular foundations, to expose their progenitor origin and track their imminent
potential, to reveal their in vivo counterparts and learn about their regenerative
potential.
Nevertheless,
cell lines with varying
differentiation potential might also aid in study of molecular regulation of
differentiation processes.
The fellow will drive a new project focusing on molecular mechanisms controlling the identity, self - renewal, and
differentiation potential of skeletal stem
cells.
In this way embryo - derived stem
cell lines and ES
cell differentiation may be providing access to
potential «transition states,» required for lineage specification in vivo.
Both mouse and human iPSCs are similar to embryonic stem
cells (ESCs) with respect to their morphology,
cell behavior, gene expression, epigenetic status and
differentiation potential both in culture and in vivo.
Her lab is examining the
potential of using biomaterials for stem
cell differentiation and engineering mesenchymal tissues.
A specific attention will be given to the identity, plasticity and
differentiation potential of the
cells required for the regeneration processes.
Finally, miR - 181a was recently shown to induce neuronal
differentiation and a DA phenotype in human long - term, self - renewing, neuroepithelial - like stem
cells [49], which supports the
potential role for miR - 181a in regulating development of mDA neurons.
But others will still remain, such as the long - term karyotypic stability, appropriate in situ localization, and
potential for wayward
differentiation of somatic
cells derived from hiPSCs.
The successful
differentiation of iPS
cells into RPE represents a significant advance in the search for a
potential cell source for the treatment of human neural retinal diseases.
Given our extensive experiences in neuronal
differentiation of hESCs [6], [7], [8] and the
potential application of hESC - derived neurons in
cell replacement therapies for neurodegenerative diseases, we designed a set of experiments aimed at developing a hESC - based automated assay for screening small molecules that have differential toxicity to hESC - derived NSCs and their differentiated neural progenies.
This poster describes the isolation and maintenance in culture of pluripotent stem
cells, their
differentiation, and the generation and
potential uses of organoids.
Collectively, these data demonstrate that youthful circulating factors can restore the self - renewal and
differentiation potential of aged SVZ stem
cells, and this effect can persist for some time after isolation from the mouse brain.